Cellebrite DI (CLBT)
Cellebrite DI Ltd. is a common stock listing on NASDAQ for a software company focused on legally sanctioned digital investigations. The company develops software and related services used to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital evidence throughout the investigative process. Its solutions support a range of matters, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, intellectual property theft, and financial crimes, including cases involving cryptocurrency. Cellebrite’s product suite includes Inseyets, Guardian Forensics, Guardian Collaborate, Guardian Investigate, Pathfinder, and Corellium’s Falcon and Viper tools. The company also provides professional services, including training, certification, and advanced services, and serves federal, state, and local agencies, as well as corporations and service providers. It is headquartered in Petah Tikva, Israel.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CLBT
|
$17.61
|
16.3% Upside
|
Fair
|
$21
|
38.7% Upside
|
Undervalued
|
Great
|
—
|
—
|
—
|
0.0%
|
August 12, 2026
|
52.6x
|
7.4x
|
7.6x
|
3.834 B
|
3.245 B
|
0.6%
|
49.6%
|
6.5
|
—
|
222.3%
|